120 related articles for article (PubMed ID: 890676)
1. A biochemical approach to the staging of human breast cancer.
Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
[No Abstract] [Full Text] [Related]
2. Biochemical markers in human breast cancer.
Coombes RC; Powles TJ; Gazet JC; Ford HT; Sloane JP; Laurence DJ; Neville AM
Lancet; 1977 Jan; 1(8003):132-4. PubMed ID: 64663
[TBL] [Abstract][Full Text] [Related]
3. Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practice.
Cowen DM; Searle F; Ward AM; Benson EA; Smiddy FG; Eaves G; Cooper EH
Eur J Cancer (1965); 1978 Aug; 14(8):885-93. PubMed ID: 80319
[No Abstract] [Full Text] [Related]
4. Biologic markers and breast cancer.
Waalkes TP; Tormey DC
Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
[No Abstract] [Full Text] [Related]
5. Biochemical monitoring of cancer. A review.
Neville AM; Cooper EH
Ann Clin Biochem; 1976 Jan; 13(1):283-305. PubMed ID: 56153
[No Abstract] [Full Text] [Related]
6. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
7. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
8. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
Lee CA; Lloyd HM
Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
[No Abstract] [Full Text] [Related]
9. Biological markers as prognostic and clinical evaluation tools.
Tormey DC; Waalkes TP
Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
[No Abstract] [Full Text] [Related]
10. Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
Statland BE; Winkel P
Crit Rev Clin Lab Sci; 1982; 16(4):255-90. PubMed ID: 6749428
[TBL] [Abstract][Full Text] [Related]
11. Serum sialic acid and CEA concentrations in human breast cancer.
Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
[TBL] [Abstract][Full Text] [Related]
12. Biological markers of human tumors and monitoring of cancer treatment.
Tanneberger S; Nissen E; Ziegenbein R
Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
[TBL] [Abstract][Full Text] [Related]
13. Markers in breast and lung cancer.
Coombes RC; Dearnaley DP; Ellison ML; Neville AM
Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():263-8. PubMed ID: 6127052
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of biochemical markers in breast cancer.
Coombes RC; Powles TJ; Neville AM
Proc R Soc Med; 1977 Dec; 70(12):843-5. PubMed ID: 601063
[No Abstract] [Full Text] [Related]
15. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer.
Bezwoda W; Derman D; Bothwell T; MacPhil P; Levin J; De Moor N
Cancer; 1981 Oct; 48(7):1623-8. PubMed ID: 7284963
[TBL] [Abstract][Full Text] [Related]
16. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
Basu TK; Donaldson D; Williams DC
Oncology; 1974; 30(3):197-203. PubMed ID: 4459734
[No Abstract] [Full Text] [Related]
17. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
Morii H; Tanae A; Ibayashi H; Nakao K
Endocrinol Jpn; 1971 Feb; 17(6):81-90. PubMed ID: 4254451
[No Abstract] [Full Text] [Related]
18. Multiple markers of malignancy in sera of patients with colorectal carcinoma: preliminary clinical studies.
Mercer DW; Talamo TS
Clin Chem; 1985 Nov; 31(11):1824-8. PubMed ID: 2414037
[TBL] [Abstract][Full Text] [Related]
19. The use of carcinoembryonic antigen and peptide hormones to stage and monitor patients with lung cancer.
Gropp C; Havemann K; Scheuer A
Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1047-53. PubMed ID: 6252125
[No Abstract] [Full Text] [Related]
20. The value of sequential marker estimations following mastectomy for breast cancer.
Coombes RC; Powles TJ; Ford HT; Gazet JC; Gehrke CW; Keyser JW; Mitchell PE; Patel S; Stimson WH; Abbott M; Worwood M; Neville AM
Eur J Cancer (1965); 1980; Suppl 1():25-30. PubMed ID: 6119202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
